Thetis Pharma
Frank Sciavolino, PhD is the Co-Founder, President & Chief Scientific Officer of Thetis Pharmaceuticals LLC, a biopharmaceutical company specializing in developing small molecule drugs for gastrointestinal diseases. With extensive experience in various advisory and executive roles in pharmaceutical companies, Frank has a strong background in research and development. Frank's educational background includes a PhD in Medicinal Chemistry from the University of Michigan.
This person is not in any offices
Thetis Pharma
Thetis is a biopharmaceutical company developing first-in-class Resolvin therapies for the treatment of cancer and autoimmune diseases. Resolvins are a unique class of endogenous molecules that regulate immune homeostasis.